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Risks associated with late-preterm
birth
The article by Gouyon et al.
1 in this issue adds to a
limited collection on the health of late-preterm in-
fants. Using a population-based dataset of over
150000 singletons born alive at 34–41 weeks gesta-
tion in Burgundy in 2000–08, the authors showed a
serial reduction with gestational age in the risk of
death or severe neurological condition, from an ad-
justed relative risk of 6.8 [95% confidence interval
(CI) 4.1–11.1] at 34 weeks to a comparative nadir at
39–41 weeks. There was a reduction in respiratory
disorders requiring oxygen and either continuous or
intermittent positive airway pressure support, from a
relative risk of 61.0 (95% CI 54.1–86.9) at 34 weeks.
They also found higher risks for infants born at 37
and 38 weeks than for later term infants, suggesting
that our view of term as running from 37 to 41 weeks
could be more nuanced. The findings are broadly
similar to those of Shapiro-Mendoza et al.
2, who
used US certification data to compare 26170
late-preterm with 377638 term infants. The risk of
morbidity doubled for each week of birth earlier
than 38 weeks, with a relative risk of 20.6 (95% CI
19.7–21.6) for infants born at 34 weeks. A
population-based Canadian study of 88867 live-born
infants showed a relative risk of respiratory morbidity
of 4.4 (95% CI 4.2–4.6) and of infection of 5.2 (95% CI
4.6–5.9) in late-preterm compared with term infants.
3
Preterm infants born in the later weeks of preg-
nancy are a relatively under-researched group.
4
Preterm labour is generally no coincidence, and in-
fants born early differ systematically from those
born at term. The maternal morbidities documented
by Gouyon et al.
1 attest to this (24% of mothers of
infants born at 34 weeks had two or more defined
antenatal complications, compared with 2% of
mothers of infants born at 39–41 weeks), as does
the fact that 17% of 34-week infants were small for
gestational age; by definition, 10% should be.
Additionally, the increased risk is not explained by
congenital abnormalities.
5,6 In 2007, Engle et al.
7 pro-
posed that we move towards an explicit acknowledg-
ment of the potential problems, defining late-preterm
as from 34
0/7 to 36
6/7 weeks after the beginning of
a mother’s last menstrual period (or 239–259 days
inclusive). Late preterm infants are more likely to
experience illness than term infants, particularly
as a result of thermal instability, hypoglycaemia,
respiratory distress, apnoea, jaundice and feeding
difficulties.
4
Implications for morbidity,
mortality and health care
There has been a tendency to see the morbidity asso-
ciated with late-preterm birth as relatively manage-
able and unlikely to have substantial population
effects on mortality and long-term morbidity, but
this view is optimistic. US figures suggest that
late-preterm accounted for 74% of all preterm in
2002,
8 and the proportion is rising.
9 In population
terms, Kramer et al.
5 showed that preterm infants
born at 34–36 weeks gestation comprised  7% of
live births in a 1995 US cohort and  5% in a 1992–
94 Canadian one. These figures imply a substantial
need for care.
10 McIntire et al.
11 analysed records of
about 250000 live-born singletons between 34 and 40
weeks gestation over 18 years in a Texas hospital, and
found that late-preterm infants made up 76% of pre-
term infants and 9% of the cohort. Three per cent of
infants born at 34 weeks required ventilation, 5%
needed intensive care and 31% were investigated for
sepsis. Shapiro-Mendoza et al.
2 described morbidity in
22% of late-preterm infants and in 52% of infants
born at 34 weeks. There is a range of projections of
the need for intensive care, with some authors sug-
gesting that as many as 50% of infants born at 34
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645weeks require it.
12 Gouyon et al.
1 describe admission
to a neonatal unit for 97% of infants born at 34
weeks, but this is likely to depend on the threshold
for admission and the level of neonatal care required.
Even in high-income countries with strong health-
care systems, late-preterm morbidity does lead to loss
of life. Khashu et al.
3 described a 5.5-fold increase in
neonatal mortality (95% CI 3.4–8.9) in 33–36-week
preterm infants compared with term infants, and
the relative risks of early neonatal death (in the
first 7 days) in the US and Canadian cohorts
described by Kramer et al.
5 were 5.2 (95% CI 4.8–
5.6) and 7.9 (95% CI 6.7–9.2), respectively. Perhaps
more tellingly, the late preterm groups contributed
aetiological fractions of 6.3 and 9.0% to early neonatal
deaths in the two cohorts, and 13.1 and 15.9% to
neonatal deaths (in the first 28 days).
Late-preterm—and even early-term—infants are,
then, at increased risk of morbidity and mortality.
The data that show this come from high-income
countries in North America and Western Europe,
with strong health-care systems and recording pro-
cesses at hospital and population level. There are,
however, broader implications. Of an estimated
3.8 million annual neonatal deaths,
13 98% occur in
low- and middle-income countries.
14 Neonatal mor-
tality currently makes up 440% of global under-5
mortality,
13 and this proportion has risen as
post-neonatal deaths have fallen, largely because of
fewer deaths from acute respiratory infection, diar-
rhoea and vaccine-preventable diseases such as mea-
sles. Our understanding of the causes of neonatal
death is limited by the fact that greater need accom-
panies weaker documentation. About 65% of births
in South Asia and East and southern Africa take
place at home,
15 and estimates of cause-specific mor-
tality rely on models and approaches such as verbal
autopsy. The three commonest causes of neonatal
death are complications of prematurity (30%), infec-
tion (28%) and intrapartum-related (‘birth asphyxia’)
(24%).
13 These broad-brush estimates are for single
causes, and there is likely to be crossover
co-morbidity. For example, both preterm delivery
and presumptive asphyxia are associated with infec-
tion. It also seems reasonable to suggest that sequelae
of late-preterm might be classified under other head-
ings, particularly if the associated morbidity has been
underestimated.
The global issue of low birth
weight
The 20 million low birth weight infants born annu-
ally, 72% of them in Asia, have an increased risk of
mortality. They constitute a variable segment of
the newborn population, from 7% in high-income
to 19% in least developed countries (and 27% in
south-central Asia).
16 Defined as a birth weight of
<2500g, low birth weight is a crude indicator that
includes infants who are preterm, infants who are
term but small and infants who are both preterm
and small for gestational age. Belizan and Villar first
pointed out that, the higher a country’s proportion of
low birth weight infants, the more of them are born
at term.
17,18A (reasonable) assumption is that this
group of term low birth weight infants have suffered
intrauterine growth restriction, and that much of this
might be explained by nutritional insufficiency
in their mothers. If most low birth weight infants
are growth restricted but mature, and if low birth
weight is on the causal pathway to neonatal mortal-
ity—runs the argument—then what we need to do is
improve fetal growth. The flaw in this argument is
that it assumes that the mortality contributed by
the term group of infants is substantial, and that
birth weight is sufficiently causal to yield mortality
reductions if tackled. This flaw may not seem import-
ant, particularly since the alternative—preventing
preterm delivery—has been an elusive goal in even
the most sophisticated clinical settings. Bound up as
it is with issues of women’s health, child health after
the neonatal period, and the right to adequate nutri-
tion, it would be inappropriate to argue against im-
proving fetal growth prospects in poor populations.
Healthier women with access to nutritious foods
have healthier, larger babies with a higher chance of
survival.
There are two problems, however. The first is that
we do not yet understand enough about the longer
term effects of changes in fetal growth trajectory. The
second is that the sequence of reasoning discussed
above might lead to disappointment if our efforts to
improve fetal growth do not lead to major reductions
in neonatal mortality. Both of these problems have
recently arisen.
The relationship between the weight of an infant
and her survival is not straightforward. Wilcox
argued that the distribution of birth weight follows
a negatively skewed bell curve, the skew accounted
for by a residual distribution of (generally) preterm
infants superimposed on a predominant distribution
of (generally) term infants.
19 The idea is that weight
itself is a limited descriptor of mortality, and that dif-
ferent groups (US Hispanic, African–American and
White European infants, infants born to mothers
who smoke and infants born in populations living
at altitude) show similar curves with different
means. A low birth weight US Hispanic infant has,
on population average, better survival prospects than
a US White European infant of identical weight. This
finding fits with the experience of neonatologists, at
least with respect to early preterm infants on inten-
sive-care units, and the same pattern seems to be seen
for late-preterm.
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minism—unjustly, in my opinion—and it may be
some comfort that subsequent work does not falsify
his hypothesis. For example, using US National
Center for Health Statistics records, Alexander et al.
8
showed higher gestation-specific survival in Black
preterm infants, followed by Hispanics and then by
Whites. However, the likelihood of being born early
followed the same sequence. The 33–36-week infants
constituted 12% of live-born Black infants, 8% of
Hispanic and 7% of White; and neonatal mortality
was higher in term Black infants.
8 The impression
(teleologically, I admit) is of resilience in the face of
greater environmental adversity. This has much in
common with the emerging body of work on the de-
velopmental origins of health and disease, which em-
phasizes the trade-off between adaptation to the
periconceptional, fetal and early infant environment
and longer term outcomes such as insulin resistance,
lipid metabolism and cardiovascular disease. New
ideas about the transgenerational effects of environ-
ment, and particularly epigenetic modification, could
explain the differences between Wilcox’s bell curves.
They also raise questions about efforts to intervene.
For example, if Indian children born in food insecure
conditions are maladapted to future food suffi-
ciency,
20 will increased nutrient availability to the
growing fetus do good or harm?
21 This is not simply
an academic question, and a great deal of research is
underway—from epigenetics to behavioural change—
to answer it.
22
The second problem lies with the choice of term
intrauterine growth restriction as a lever for prevent-
ing neonatal mortality in low birth weight infants in
low-income countries. One might see this as the
result of limited consideration of population attribut-
able risk, although the statistics on which to base
calculations are scanty in the populations at most
risk; assignment of gestational age is difficult and
population-based studies are few. In an analysis of
outcomes for low birth weight infants born at a hos-
pital in Dhaka, Bangladesh, Yasmin et al.
23 found that
75% of deaths occurred in the preterm group, al-
though it constituted only 39% of the cohort. With
respect to later preterm, infants of 32–36 weeks ges-
tation contributed an aetiological fraction of 55%. This
begged the question (already asked by Wilcox) of
whether a focus on growth might have only limited
effects on survival. Efforts to improve outcomes have
had disappointing results, an example being the rela-
tive lack of success of public health programmes to
prevent low birth weight.
24 Another example is the
recent experience of trials of antenatal multiple
micronutrient supplementation, which is associated
with increases in birth weight that do not seem to
translate into increased neonatal survival.
25,26
Although this may be explained by the modest
weight increase (macronutrient supplementation
appears to be associated with greater weight incre-
ments and some reduction in neonatal mortality),
27
it is a sobering finding.
How much of neonatal mortality
is attributable to late-preterm?
We can only speculate on the fraction of neonatal
mortality attributable to late-preterm in low-income
countries. Rates of preterm birth do appear to be
higher than in high-income settings (12.3%, for
example, in a population-based study from South
India),
28 but gestation-specific mortality rates are
largely unknown. Using records of preterm infants
born at a tertiary hospital in Nigeria, Kuti and Owa
found essentially zero survival for infants born at ges-
tations of <28 weeks. The data presented in their
article suggest a neonatal mortality rate of 370 per
1000 for infants <34 weeks, and 48 for infants 34–
36 weeks, an 8-fold difference. What we do not know
is how late-preterm morbidity of the degree described
by Gouyon et al.
1 is reflected in survival rates in popu-
lations where clinical support does not reach many
newborn infants.
Speculatively, we could estimate aetiologic fraction
(EF) using the approach described by Miettinen and
others:
5,29,30
EF ¼ Pi ðRRi   1Þ=
X
Pi ðRRi   1Þþ1
where Pi is the prevalence of the i-th gestational age
category (preterm <34
0/7, late-preterm 34
0/7 to 36
6/7),
RRi is the relative risk of mortality in the group com-
pared to the term category, and  indicates summa-
tion over the i preterm categories. Assuming a relative
risk of mortality in late-preterm infants of about
5 (based on a middle figure from the studies already
discussed), a relative risk of, say, 20 in infants born
before 34
0/7 and a population proportion of 12% for
preterm birth, of which 75% are late-preterm, the esti-
mated EF for late-preterm is  19%. Varying the rela-
tive risk of earlier preterm between 10 and 30 moves
the EF between 22 and 16%. If the relative risk of
earlier preterm is moved any higher, the combined
aetiological fraction for preterm becomes implausibly
high. On the other hand, a relative risk of 5 seems
conservative given that this is what is observed in
hospital settings in high-income countries, and the
estimates do not include twins, whose mortality is
higher and whose births cluster in the late-preterm
category. The imprecision of these estimates notwith-
standing, if preterm accounts for at least 30% of neo-
natal mortality in low-income countries, it seems
reasonable to propose that between a third and half
of this could be accounted for by late-preterm: be-
tween 10 and 15% of global neonatal deaths.
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The article by Gouyon et al.
1 should stimulate a little
more consideration before late-preterm elective induc-
tion of labour or operative delivery in the hospitals of
the North. If it makes us think about the toll that
late-preterm birth may be taking in the global
South, all the better. A recent analysis by Kramer
and colleagues raises the question of whether we
could profitably turn our attention to managing the
consequences of low birth weight rather than prevent-
ing it.
28 We need to encourage mothers, families and
health professionals to think about low-intensity
home and hospital interventions that could improve
the survival of late-preterm infants. Over the last two
decades, newborn survival initiatives have emphasized
hygienic delivery, early and exclusive breastfeeding,
skin-to-skin contact (late-preterm infants are ideal
candidates for Kangaroo mothercare) and early treat-
ment for signs of illness. Our developing understand-
ing of the hazards of late-preterm birth supports this
approach unequivocally.
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